Enzymaster Completed Series B-1 Financing

Enzymaster Press release

Enzymaster, a global biotech company with locations in China, Germany and Singapore specialized in biocatalysis and enzyme engineering, announced the close of a US$ 7.5 Mio (CNY 50 Mio) Series B-1 funding.

request quote or ask a question